Bank of New York Mellon’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6M | Buy |
449,694
+31,680
| +8% | +$1.03M | ﹤0.01% | 1685 |
|
|
2025
Q1 | $15.8M | Sell |
418,014
-3,924
| -0.9% | -$148K | ﹤0.01% | 1620 |
|
|
2024
Q4 | $34.5M | Buy |
421,938
+9,888
| +2% | +$809K | 0.01% | 1253 |
|
|
2024
Q3 | $47.1M | Sell |
412,050
-56,529
| -12% | -$6.46M | 0.01% | 1079 |
|
|
2024
Q2 | $35.4M | Buy |
468,579
+56,054
| +14% | +$4.23M | 0.01% | 1231 |
|
|
2024
Q1 | $28.2M | Buy |
412,525
+13,408
| +3% | +$916K | 0.01% | 1381 |
|
|
2023
Q4 | $25.1M | Buy |
399,117
+3,086
| +0.8% | +$194K | 0.01% | 1477 |
|
|
2023
Q3 | $20.2M | Buy |
396,031
+14,375
| +4% | +$733K | ﹤0.01% | 1537 |
|
|
2023
Q2 | $19.1M | Buy |
381,656
+80,610
| +27% | +$4.03M | ﹤0.01% | 1578 |
|
|
2023
Q1 | $11.3M | Sell |
301,046
-6,602
| -2% | -$247K | ﹤0.01% | 1872 |
|
|
2022
Q4 | $14.8M | Buy |
307,648
+128,078
| +71% | +$6.14M | ﹤0.01% | 1718 |
|
|
2022
Q3 | $4.31M | Buy |
179,570
+23,493
| +15% | +$564K | ﹤0.01% | 2365 |
|
|
2022
Q2 | $3.4M | Buy |
156,077
+3,713
| +2% | +$80.8K | ﹤0.01% | 2531 |
|
|
2022
Q1 | $3.68M | Buy |
152,364
+6,891
| +5% | +$166K | ﹤0.01% | 2584 |
|
|
2021
Q4 | $3.46M | Buy |
145,473
+7,875
| +6% | +$187K | ﹤0.01% | 2660 |
|
|
2021
Q3 | $3.49M | Buy |
137,598
+19,092
| +16% | +$484K | ﹤0.01% | 2677 |
|
|
2021
Q2 | $2.67M | Buy |
118,506
+33,669
| +40% | +$758K | ﹤0.01% | 2817 |
|
|
2021
Q1 | $1.68M | Buy |
84,837
+18,897
| +29% | +$373K | ﹤0.01% | 3027 |
|
|
2020
Q4 | $1.75M | Buy |
65,940
+12,925
| +24% | +$343K | ﹤0.01% | 2921 |
|
|
2020
Q3 | $2.62M | Buy |
+53,015
| New | +$2.62M | ﹤0.01% | 2520 |
|